États-Unis · Plateformes & données · Finviz

DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination

Publié par Finviz · États-Unis il y a 10 h

Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard Time Upon closing,…

Lire l'article complet sur Finviz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finviz.com)

DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination

À lire aussi

Abbott Laboratories (NYSE:ABT) Stock Sale Revealed by Rep. Thomas H. Kean, Jr.

Michael Burry adds to BYD, SFM, JD, sees up to 140% potential in Fiserv

Blackstone president calls for more equity to fund AI buildout as debt risks mount

Vertex (VRTX) Q3 2026 Earnings Call Transcript

Why is Virgin Australia stock surging today?

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter

DSS, Inc. Announces SEC Declaration of Effectiveness of Form F-4 Registration Statement, Marking Major Milestone Toward Closing of Proposed Business Combination

Partager

À lire aussi

Abbott Laboratories (NYSE:ABT) Stock Sale Revealed by Rep. Thomas H. Kean, Jr.

Michael Burry adds to BYD, SFM, JD, sees up to 140% potential in Fiserv

Blackstone president calls for more equity to fund AI buildout as debt risks mount

Vertex (VRTX) Q3 2026 Earnings Call Transcript

Why is Virgin Australia stock surging today?

Here’s why Palantir’s stock is down despite a ‘bombastic’ quarter